PaxMedica, Inc. Common Stock
PXMD · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,259 | $17,746 | $57,837 | $49,180 |
| - Cash | $4,711 | $1,902 | $444 | $1,124 |
| + Debt | $0 | $174 | $0 | $612 |
| Enterprise Value | -$3,452 | $16,017 | $57,393 | $48,668 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$16,145 | -$16,508 | -$7,198 | -$5,619 |
| % Margin | – | – | – | – |
| Net Income | -$18,290 | -$14,802 | -$13,035 | -$8,489 |
| % Margin | – | – | – | – |
| EPS Diluted | -11 | -28.73 | -18.81 | -13.42 |
| % Growth | 61.7% | -52.7% | -40.2% | – |
| Operating Cash Flow | -$10,769 | -$6,071 | -$5,513 | -$2,349 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$10,769 | -$6,071 | -$5,513 | -$2,349 |